UniProt ID | CXA1_HUMAN | |
---|---|---|
UniProt AC | P17302 | |
Protein Name | Gap junction alpha-1 protein | |
Gene Name | GJA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 382 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Cell junction, gap junction . Endoplasmic reticulum . Localizes at the intercalated disk (ICD) in cardiomyocytes and the proper localization at ICD is dependent on TMEM65. |
|
Protein Description | Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, thus sensitizing bladder muscles to cholinergic neural stimuli and causing them to contract (By similarity). May play a role in cell growth inhibition through the regulation of NOV expression and localization. Plays an essential role in gap junction communication in the ventricles (By similarity).. | |
Protein Sequence | MGDWSALGKLLDKVQAYSTAGGKVWLSVLFIFRILLLGTAVESAWGDEQSAFRCNTQQPGCENVCYDKSFPISHVRFWVLQIIFVSVPTLLYLAHVFYVMRKEEKLNKKEEELKVAQTDGVNVDMHLKQIEIKKFKYGIEEHGKVKMRGGLLRTYIISILFKSIFEVAFLLIQWYIYGFSLSAVYTCKRDPCPHQVDCFLSRPTEKTIFIIFMLVVSLVSLALNIIELFYVFFKGVKDRVKGKSDPYHATSGALSPAKDCGSQKYAYFNGCSSPTAPLSPMSPPGYKLVTGDRNNSSCRNYNKQASEQNWANYSAEQNRMGQAGSTISNSHAQPFDFPDDNQNSKKLAAGHELQPLAIVDQRPSSRASSRASSRPRPDDLEI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MGDWSALGKLLD ---CCCHHHHHHHHH | 20.53 | - | |
9 | Ubiquitination | GDWSALGKLLDKVQA CCHHHHHHHHHHHHH | 46.88 | 21890473 | |
109 | Ubiquitination | KEEKLNKKEEELKVA HHHHHCHHHHHHHHH | 70.10 | - | |
114 | Ubiquitination | NKKEEELKVAQTDGV CHHHHHHHHHHCCCC | 38.51 | - | |
128 | Ubiquitination | VNVDMHLKQIEIKKF CCCHHEEEEEEEEEC | 34.25 | - | |
136 | Ubiquitination | QIEIKKFKYGIEEHG EEEEEECCCCHHHCC | 51.99 | - | |
137 | Phosphorylation | IEIKKFKYGIEEHGK EEEEECCCCHHHCCC | 26.86 | 28348404 | |
144 | Ubiquitination | YGIEEHGKVKMRGGL CCHHHCCCEEECCHH | 40.36 | - | |
144 | Sumoylation | YGIEEHGKVKMRGGL CCHHHCCCEEECCHH | 40.36 | 22411987 | |
148 | Methylation | EHGKVKMRGGLLRTY HCCCEEECCHHHHHH | 30.25 | - | |
237 | Sumoylation | YVFFKGVKDRVKGKS HHHHHCCHHHHCCCC | 48.78 | 22411987 | |
243 | Ubiquitination | VKDRVKGKSDPYHAT CHHHHCCCCCCCCCC | 46.07 | - | |
244 | Phosphorylation | KDRVKGKSDPYHATS HHHHCCCCCCCCCCC | 53.11 | - | |
247 | Phosphorylation | VKGKSDPYHATSGAL HCCCCCCCCCCCCCC | 14.74 | 21082442 | |
250 | Phosphorylation | KSDPYHATSGALSPA CCCCCCCCCCCCCCC | 17.87 | 23403867 | |
251 | Phosphorylation | SDPYHATSGALSPAK CCCCCCCCCCCCCCH | 23.89 | 19664994 | |
255 | Phosphorylation | HATSGALSPAKDCGS CCCCCCCCCCHHHCC | 23.44 | 19664994 | |
258 | Ubiquitination | SGALSPAKDCGSQKY CCCCCCCHHHCCCCE | 57.86 | - | |
262 | Phosphorylation | SPAKDCGSQKYAYFN CCCHHHCCCCEEEEC | 29.81 | 22737133 | |
264 | Ubiquitination | AKDCGSQKYAYFNGC CHHHCCCCEEEECCC | 33.28 | - | |
265 | Phosphorylation | KDCGSQKYAYFNGCS HHHCCCCEEEECCCC | 10.01 | 11514593 | |
267 | Phosphorylation | CGSQKYAYFNGCSSP HCCCCEEEECCCCCC | 8.42 | 22199227 | |
271 | S-nitrosocysteine | KYAYFNGCSSPTAPL CEEEECCCCCCCCCC | 3.69 | - | |
271 | S-nitrosylation | KYAYFNGCSSPTAPL CEEEECCCCCCCCCC | 3.69 | - | |
272 | Phosphorylation | YAYFNGCSSPTAPLS EEEECCCCCCCCCCC | 40.53 | 22199227 | |
273 | Phosphorylation | AYFNGCSSPTAPLSP EEECCCCCCCCCCCC | 30.28 | 22199227 | |
275 | Phosphorylation | FNGCSSPTAPLSPMS ECCCCCCCCCCCCCC | 42.74 | 22199227 | |
279 | Phosphorylation | SSPTAPLSPMSPPGY CCCCCCCCCCCCCCC | 19.93 | 22737133 | |
282 | Phosphorylation | TAPLSPMSPPGYKLV CCCCCCCCCCCCEEC | 31.18 | 15605363 | |
286 | Phosphorylation | SPMSPPGYKLVTGDR CCCCCCCCEECCCCC | 13.61 | 22199227 | |
287 | Ubiquitination | PMSPPGYKLVTGDRN CCCCCCCEECCCCCC | 42.25 | - | |
290 | Phosphorylation | PPGYKLVTGDRNNSS CCCCEECCCCCCCHH | 43.74 | 30266825 | |
296 | Phosphorylation | VTGDRNNSSCRNYNK CCCCCCCHHCCCCCH | 34.07 | 30266825 | |
297 | Phosphorylation | TGDRNNSSCRNYNKQ CCCCCCHHCCCCCHH | 21.15 | 30266825 | |
301 | Phosphorylation | NNSSCRNYNKQASEQ CCHHCCCCCHHHHHC | 12.37 | 23403867 | |
303 | Ubiquitination | SSCRNYNKQASEQNW HHCCCCCHHHHHCHH | 36.56 | 21890473 | |
306 | Phosphorylation | RNYNKQASEQNWANY CCCCHHHHHCHHHHH | 36.90 | 26503892 | |
313 | Phosphorylation | SEQNWANYSAEQNRM HHCHHHHHHHHHHCC | 11.08 | 21945579 | |
314 | Phosphorylation | EQNWANYSAEQNRMG HCHHHHHHHHHHCCC | 25.74 | 19664994 | |
325 | Phosphorylation | NRMGQAGSTISNSHA HCCCCCCCCCCCCCC | 26.11 | 26503892 | |
326 | Phosphorylation | RMGQAGSTISNSHAQ CCCCCCCCCCCCCCC | 27.75 | 30266825 | |
328 | Phosphorylation | GQAGSTISNSHAQPF CCCCCCCCCCCCCCC | 32.16 | 26503892 | |
330 | Phosphorylation | AGSTISNSHAQPFDF CCCCCCCCCCCCCCC | 17.26 | 30266825 | |
344 | Phosphorylation | FPDDNQNSKKLAAGH CCCCCCCCCCCCCCC | 22.77 | 23403867 | |
345 | Ubiquitination | PDDNQNSKKLAAGHE CCCCCCCCCCCCCCC | 60.39 | - | |
346 | Ubiquitination | DDNQNSKKLAAGHEL CCCCCCCCCCCCCCC | 43.08 | - | |
364 | Phosphorylation | AIVDQRPSSRASSRA EEECCCCCCCHHHCC | 34.35 | 26503892 | |
365 | Phosphorylation | IVDQRPSSRASSRAS EECCCCCCCHHHCCC | 34.25 | 26503892 | |
368 | Phosphorylation | QRPSSRASSRASSRP CCCCCCHHHCCCCCC | 21.17 | 26503892 | |
369 | Phosphorylation | RPSSRASSRASSRPR CCCCCHHHCCCCCCC | 30.77 | 26503892 | |
372 | Phosphorylation | SRASSRASSRPRPDD CCHHHCCCCCCCCCC | 26.27 | 30266825 | |
373 | Phosphorylation | RASSRASSRPRPDDL CHHHCCCCCCCCCCC | 45.37 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
247 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
255 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
255 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
262 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
265 | Y | Phosphorylation | Kinase | SRC | Q9WUD9 | PSP |
265 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
279 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
279 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
282 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
282 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
313 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
325 | S | Phosphorylation | Kinase | CK1 | - | Uniprot |
325 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
325 | S | Phosphorylation | Kinase | CK1A | P48729 | PSP |
328 | S | Phosphorylation | Kinase | CK1 | - | Uniprot |
328 | S | Phosphorylation | Kinase | CK1A | P48729 | PSP |
328 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
330 | S | Phosphorylation | Kinase | CK1 | - | Uniprot |
330 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
330 | S | Phosphorylation | Kinase | CK1A | P48729 | PSP |
364 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
365 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
368 | S | Phosphorylation | Kinase | PRKCG | P05129 | Uniprot |
368 | S | Phosphorylation | Kinase | PRKCE | Q02156 | GPS |
368 | S | Phosphorylation | Kinase | PRKCD | Q05655 | Uniprot |
368 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
369 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
372 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
373 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
373 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:19835873 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CXA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MK07_HUMAN | MAPK7 | physical | 12637502 | |
CXA1_HUMAN | GJA1 | physical | 11739633 | |
CXA3_HUMAN | GJA3 | physical | 11739633 | |
CXA5_HUMAN | GJA5 | physical | 11557558 | |
KC1D_HUMAN | CSNK1D | physical | 12270943 | |
ZO1_HUMAN | TJP1 | physical | 9707407 | |
KPCE_HUMAN | PRKCE | physical | 10679481 | |
CAV1_HUMAN | CAV1 | physical | 11980479 | |
NEDD4_HUMAN | NEDD4 | physical | 19907029 | |
HGS_HUMAN | HGS | physical | 19808888 | |
TS101_HUMAN | TSG101 | physical | 19808888 | |
EPS15_HUMAN | EPS15 | physical | 21554242 | |
NEDD4_HUMAN | NEDD4 | physical | 19835873 | |
UBQL4_HUMAN | UBQLN4 | physical | 20940304 | |
UBQL4_HUMAN | UBQLN4 | physical | 18079109 | |
UBQL4_HUMAN | UBQLN4 | physical | 24256120 | |
PSMD2_HUMAN | PSMD2 | physical | 24256120 | |
EPS15_HUMAN | EPS15 | physical | 25070368 | |
STABP_HUMAN | STAMBP | physical | 25070368 | |
STXB2_HUMAN | STXBP2 | physical | 26186194 | |
NDUA7_HUMAN | NDUFA7 | physical | 26186194 | |
STXB1_HUMAN | STXBP1 | physical | 26186194 | |
EF1A2_HUMAN | EEF1A2 | physical | 26186194 | |
STXB1_HUMAN | STXBP1 | physical | 28514442 | |
STXB2_HUMAN | STXBP2 | physical | 28514442 | |
1433T_HUMAN | YWHAQ | physical | 17008717 | |
1433Z_HUMAN | YWHAZ | physical | 17008717 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00449 | Oculodentodigital dysplasia | |||||
H00605 | Deafness, autosomal recessive | |||||
H01095 | Syndactyly | |||||
H01272 | Hypoplastic left heart syndrome (HLHS) | |||||
OMIM Disease | ||||||
164200 | Oculodentodigital dysplasia (ODDD) | |||||
257850 | Oculodentodigital dysplasia, autosomal recessive (ODDD-AR) | |||||
186100 | Syndactyly 3 (SDTY3) | |||||
241550 | Hypoplastic left heart syndrome 1 (HLHS1) | |||||
234100 | Hallermann-Streiff syndrome (HSS) | |||||
600309 | Atrioventricular septal defect 3 (AVSD3) | |||||
218400 | Craniometaphyseal dysplasia, autosomal recessive (CMDR) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Casein kinase 1 regulates connexin-43 gap junction assembly."; Cooper C.D., Lampe P.D.; J. Biol. Chem. 277:44962-44968(2002). Cited for: PHOSPHORYLATION AT SER-325; SER-328 AND SER-330 BY CSNK1D/CK1, ANDINTERACTION WITH CSNK1D. | |
"Phosphorylation of serine 262 in the gap junction protein connexin-43regulates DNA synthesis in cell-cell contact forming cardiomyocytes."; Doble B.W., Dang X., Ping P., Fandrich R.R., Nickel B.E., Jin Y.,Cattini P.A., Kardami E.; J. Cell Sci. 117:507-514(2004). Cited for: PHOSPHORYLATION AT SER-262. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-247 AND TYR-313, ANDMASS SPECTROMETRY. |